Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 6
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Meguro, Kenichi Ouchi, Yoshitaka Akanuma, Kyoko Meguro, Mitsue and Kasai, Mari 2014. Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer’s patients in long-term care health facilities. BMC Neurology, Vol. 14, Issue. 1,


    Hoe, Juanita Cooper, Claudia and Livingston, Gill 2013. An overview of the LASER-AD study: A longitudinal epidemiological study of people with Alzheimer's disease. International Review of Psychiatry, Vol. 25, Issue. 6, p. 659.


    Ferris, Steven Ihl, Ralf Robert, Philippe Winblad, Bengt Gatz, Gudrun Tennigkeit, Frank and Gauthier, Serge 2009. Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's disease patients. Alzheimer's & Dementia, Vol. 5, Issue. 5, p. 375.


    Winblad, Bengt Black, Sandra E. Homma, Akira Schwam, Elias M. Moline, Margaret Xu, Yikang Perdomo, Carlos A. Swartz, Jina and Albert, Kenneth 2009. Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials. Current Medical Research and Opinion, Vol. 25, Issue. 11, p. 2577.


    Cooper, Claudia Manela, Monica Katona, Cornelius and Livingston, Gill 2008. Screening for elder abuse in dementia in the LASER-AD study: prevalence, correlates and validation of instruments. International Journal of Geriatric Psychiatry, Vol. 23, Issue. 3, p. 283.


    2007. Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry, Vol. 22, Issue. 5, p. 503.


    ×

Characteristics and health status change over 6 months in people with moderately severe to severe Alzheimer's disease in the U.K.

  • Gill Livingston (a1), Cornelius Katona (a2), Clèment François (a3), Chantal Guilhaume (a3), John Cochran (a3) and Christophe Sapin (a4)
  • DOI: http://dx.doi.org/10.1017/S1041610205002942
  • Published online: 01 February 2006
Abstract

Background and objectives: Until recently, attention and treatment strategies have focused mainly on patients in the early phases of Alzheimer's disease (AD). The objectives of this study were to collect information on moderately severe and severe AD patients (Mini-mental State Examination score < 15) in terms of epidemiological, clinical and economic characteristics and disease change in the later stages of AD, and to compare this specific AD population over 6 months with those in the earlier stages.

Methods: This descriptive analysis recruited institutionalized patients and patients living within the community from the city of London and the South-East region of the U.K. Subgroup analyses at baseline and 6 months were performed using the study population from the London and South-East Region Alzheimer's Disease (LASER-AD) Study. Data from a range of clinical scales, a quality of life (QOL) scale and a resource-utilization questionnaire were analyzed.

Results: People with moderately severe or severe AD are a heterogeneous group with varying QOL, cognitive and functional disabilities, neuropsychological symptoms and relatively low health care resource consumption. This patient group continued to decline but progression of the disease was observed only in some domains.

Conclusion: Even at the later stages of AD, patients show varying rates of decline. Improved knowledge about the characteristics and progression of the disease reveals that moderately severe and severe patients cannot be regarded as beyond help and have the potential to experience varying and even high levels of QoL.

Copyright
Corresponding author
Correspondence should be addressed to: Chantal Guilhaume, H. Lundbeck A/S, Health Economics and Epidemiology Department, 37, Avenue Pierre 1er de Serbie, F-75008 Paris, France. Phone: +331 53 67 42 00; Fax: +331 53 67 42 67. Email: chgu@lundbeck.com.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: